Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database.
Zheng F, Du Y, Yuan Y, Wang Z, Li S, Xiong S, Zeng J, Tan Y, Liu X, Xu S, Fu B, Liu W.
Zheng F, et al. Among authors: wang z.
Heliyon. 2024 Sep 6;10(18):e37544. doi: 10.1016/j.heliyon.2024.e37544. eCollection 2024 Sep 30.
Heliyon. 2024.
PMID: 39309793
Free PMC article.